Rifampicin-Resistant Tuberculosis
12 clinical trials · Condition
◉ Watch Rifampicin-Resistant Tuberculosis
| Record | Firm | Date |
|---|---|---|
| Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB) (NCT05081401) | Huashan Hospital | 2022-05-23 |
| Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial (NCT05017324) | Universiteit Antwerpen | 2021-09-21 |
| Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care (NCT04062201) | Wits Health Consortium (Pty) Ltd | 2019-08-22 |
| GeneXpert Performance Evaluation for Linkage to Tuberculosis Care (NCT03044158) | University of California, San Francisco | 2018-10-22 |
| Line Probe Assay Evaluation Study (NCT02984579) | Foundation for Innovative New Diagnostics, Switzerland | 2015-03-01 |
Track Rifampicin-Resistant Tuberculosis automatically
Every clearance here is in the API, with alerts when new ones post.